Skip to main content
Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.510
-0.070 (-12.07%)
At close: Feb 27, 2026

Clearside Biomedical Revenue

Clearside Biomedical had revenue of $201.00K in the quarter ending September 30, 2025, a decrease of -80.64%. This brings the company's revenue in the last twelve months to $3.33M, down -56.78% year-over-year. In the year 2024, Clearside Biomedical had annual revenue of $1.66M, down -79.77%.

Revenue (ttm)
3.33M
Revenue Growth
-56.78%
P/S Ratio
0.80
Revenue / Employee
104.03K
Employees
32
Market Cap
2.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.66M-6.56M-79.77%
Dec 31, 20238.23M6.90M519.89%
Dec 31, 20221.33M-28.25M-95.51%
Dec 31, 202129.58M21.68M274.65%
Dec 31, 20207.89M5.72M263.28%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
LakeShore Biopharma 84.75M
Enzolytics 46.59K
Enzon Pharmaceuticals 26.00K
AXIM Biotechnologies 92.90K
Vaccinex 601.00K
Sorrento Therapeutics 64.27M
Revenue Rankings

Clearside Biomedical News

More News